Literature DB >> 23622335

Systemic inflammatory and autoimmune disorders.

Daniela Pohl1, Susanne Benseler.   

Abstract

Systemic disorders with possible involvement of the nervous system include a variety of diseases with presumed inflammatory and autoimmune pathomechanisms, among them Behçet disease, sarcoidosis, systemic lupus erythematosus, juvenile idiopathic arthritis, scleroderma, and Sjögren syndrome. This disease group encompasses systemic inflammatory disorders with a genetically defined dysregulation of the innate immune system as well as systemic autoimmune disorders characterized by alterations of the adaptive immunity such as autoantibodies and autoreactive T cells. Although more commonly diagnosed in adults, all of these diseases can manifest in childhood and some as early as infancy. Neurological involvement may represent the initial manifestation, and nearly every neurological symptom can be caused by inflammatory/autoimmune diseases. In a child with (sub)acute onset of otherwise unexplained neurological findings, consideration of inflammatory/autoimmune disorders may be of crucial therapeutic and prognostic importance. In the absence of disease-specific clinical features, the initial diagnostic workup is broad. Basic blood tests include inflammatory markers and autoantibodies. Cerebral magnetic resonance imaging and a lumbar puncture with measurement of opening pressure as well as cerebrospinal fluid analysis are indicated in most patients with central nervous system (CNS) involvement. Skin, muscle, or organ biopsies (e.g., renal) may provide additional information. Especially in patients with isolated CNS involvement, a brain biopsy may be indicated. Timely recognition and treatment of CNS inflammation may improve or even reverse clinical symptoms and prevent secondary brain injury.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23622335     DOI: 10.1016/B978-0-444-52910-7.00047-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  8 in total

Review 1.  Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.

Authors:  Sophie I Mavrogeni; Petros P Sfikakis; Theodoros Dimitroulas; Loukia Koutsogeorgopoulou; Gikas Katsifis; George Markousis-Mavrogenis; Genovefa Kolovou; George D Kitas
Journal:  Rheumatol Int       Date:  2018-03-07       Impact factor: 2.631

Review 2.  "Save the Last Dance" for Cardiovascular Magnetic Resonance.

Authors:  Sophie I Mavrogeni; George Markousis-Mavrogenis; Genovefa Kolovou
Journal:  Eur Cardiol       Date:  2018-12

3.  Elevation of Tear MMP-9 Concentration as a Biomarker of Inflammation in Ocular Pathology by Antibody Microarray Immunodetection Assays.

Authors:  Miguel de la Fuente; Iñaki Rodríguez-Agirretxe; Elena Vecino; Egoitz Astigarraga; Arantxa Acera; Gabriel Barreda-Gómez
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 4.  Targeting Scavenger Receptors in Inflammatory Disorders and Oxidative Stress.

Authors:  Govigerel Bayarsaikhan; Delger Bayarsaikhan; Jaewon Lee; Bonghee Lee
Journal:  Antioxidants (Basel)       Date:  2022-05-09

Review 5.  Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).

Authors:  Karen G Ordovas; Lauren A Baldassarre; Chiara Bucciarelli-Ducci; James Carr; Juliano Lara Fernandes; Vanessa M Ferreira; Luba Frank; Sophie Mavrogeni; Ntobeko Ntusi; Ellen Ostenfeld; Purvi Parwani; Alessia Pepe; Subha V Raman; Hajime Sakuma; Jeanette Schulz-Menger; Lilia M Sierra-Galan; Anne Marie Valente; Monvadi B Srichai
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-10       Impact factor: 5.364

Review 6.  Cardiac MRI in Autoimmune Diseases: Where Are We Now?

Authors:  Natalia G Vallianou; Eleni Geladari; Fotis Panagopoulos; Maria Kalantzi
Journal:  Curr Cardiol Rev       Date:  2021

Review 7.  Inflammation, Cancer and Immunity-Implication of TRPV1 Channel.

Authors:  Joanna Katarzyna Bujak; Daria Kosmala; Iwona Monika Szopa; Kinga Majchrzak; Piotr Bednarczyk
Journal:  Front Oncol       Date:  2019-10-16       Impact factor: 6.244

8.  The Role of Cardiovascular Imaging in the Evaluation of Rheumatic and Neuromuscular Disorders.

Authors:  Sophie I Mavrogeni
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.